Item Name |
Specification |
Product Name |
BPC-157 |
Appearance |
White Powder |
CAS |
137525-51-0 |
MF |
C62H98N16O22 |
MW |
1419.56 |
Purity |
>99% |
Storage |
Keep in dark place,Inert atmosphere,Store in freezer, under -20°C |
BPC-157, which stands for Body Protection Compound-157, is obtained from the parent protein known as body protection compound (BPC). BPC is a naturally occurring protein in the digestive tract[1]. Research suggests that it protects the gastrointestinal tract lining from damage, mediates healing, and encourages the growth of blood vessels. BPC 157 is a penta-decapeptide made up of 15 amino acids. It is derived from a stretch of the body protection compound (BPC) discovered and purified from human gastric juice. Animal studies have observed its potential efficacy in healing different wounds such as muscle, tendon, and torn ligaments. It may further protect organs and help to prevent gastric ulcers[2]. Sikiric et al noted that there was a strong protection, noted following intragastric or intraperitoneal administration of BPC 157. BPC-157 also has the potential to enhance the health of the digestive tract and prevent against irritable bowel syndrome (IBS), gastrointestinal cramps, and Crohn’s disease. The peptide also has analgesic properties, and by promoting the blood flow to the damaged tissues, it may help heal skin burns faster.
The synthetic peptide appears to have retained several of the healing properties of its parent molecule, such as:
– Blood vessel growth
– Wound healing
– Nitric oxide generation
– Immune system function
– The coagulation cascade
– Gene expression
– Hormone regulation (specifically in the gastrointestinal, nervous system)
BPC-157 AND WOUND HEALING
The GI tract’s mucosal barrier is considered to help protect the underlying tissues from the harmful actions of bile, gastric acid, and other compounds necessary for the digestion and absorption of nutrients from food. BPC-157 is believed to help preserve the structural integrity of the mucosal layer. The role appears to be partially mediated through the recruitment of fibroblasts. Fibroblasts are considered pivotal to healing wounds as they produce extracellular matrix proteins such as fibrin, collagen, elastin, and others. BPC-157 has been observed to promote the proliferation and faster migration of fibroblasts in a concentration-dependent manner.[3] In another trial it was hypothesized that BPC-157 may have led to an acceleration in wound closure compared to the control group via an improvement in the formation of granulation tissue, reepithelialization, dermal remodeling, and collagen deposition. There is a possibility that BPC-157 may have promoted the expression of vascular endothelial growth factor (VEGF) in the injured skin tissues[4]. Moreover, the researchers commented that BPC-157 may have shown a potential to enhance umbilical vein endothelial cell proliferation (HUVECs). Furthermore, there may have been a significant increase in the migration of HUVECs, as indicated by the comments from wound healing assays. Adding BPC-157 possibly resulted in an upregulation of VEGF-a expression and acceleration of vascular tube formation in vitro. It also appeared that BPC-157 might have regulated the phosphorylation level of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and their downstream targets, including c-Fos, c-Jun, and Egr-1. These molecules are hypothesized to potentially play significant roles in cell growth, migration, and angiogenesis.[4]
BPC-157 AND VASCULAR GROWTH AND COLLATERALIZATION
The peptide has the potential as an angiogenic, and studies suggest it may enhance endothelial cells’ growth and proliferation, which line the walls of blood vessels. Research in rats has observed that the peptide may substantially increase the collateral blood vessel growth rate in the setting of ischemia.[5] The above effect has been primarily observed in the GI tract, but research has noted similar observations in muscle, neurological, and cardiovascular tissues. Research using chicken embryos has posited that BPC-157 may also have the potential to promote vascular growth through activation of VEGFR2 pathway. VEGFR2 is a cell surface receptor active in nitric oxide signaling and is considered to help in cell growth, longevity, and proliferation. BPC-157 may promote vascular “running” in cultured cells. Vascular “running” is the growth and development of new blood vessels towards a site of injury or around the area of blood clot to reach out to distal tissues and thus protect cellular function.
BPC-157 AND TENDON HEALING
BPC-157 studies have observed positive potential in connective tissue healing such as ligament, bone, and tendon. Ligament and tendon injuries take a long time to heal due to the poor blood supply to these tissues. There is slower migration of fibroblasts and wound-healing cells to these sites of injury owing to the poor blood supply, and therefore the repair process is obstructed. The peptide has the potential to improve the collateralization and density of fibroblasts in the sites of injury in research involving rat tendons.[6] More specifically, the study also hypothesized that BPC-157 might significantly accelerate the outgrowth of tendon fibroblasts from tendon explants. This suggests that BPC-157 may potentially promote the growth of new cells in the injured tendon. Further, the survival of the cells to which BPC-157 was applied may be significantly increased when exposed to H(2)O(2) stress, indicating a potential protective action against oxidative stress. BPC-157 may also enhance the migration of tendon fibroblasts, as indicated by the transwell filter migration assay used in the study. This may imply that BPC-157 potentially promotes the movement of tendon fibroblasts, which may be important for tissue repair. Moreover, BPC-157 may accelerate the spreading of tendon fibroblasts on culture dishes, suggesting potentially increased cell adhesion and attachment.[6]
This experimental research has suggested BPC-157 to be a more positive impactor than EFG, bFGF, and VGF hormones. Immunostaining assays involving FITC conjugated phalloidin have observed BPC-157 to enhance F-actin formation in fibroblasts. F-actin is crucial for cell structure and function and promotes cell migration. Immunoblotting experiments have noted that BPC-157 appears to increase the phosphorylation of paxillin and FAK proteins which are crucial for cellular migration. More specifically, BPC-157 may induce F-actin formation in tendon fibroblasts, potentially indicating enhanced cytoskeletal organization and cell motility. Further analysis using Western blotting indicates that BPC-157 may activate the FAK (focal adhesion kinase) and paxillin proteins. The phosphorylation levels of FAK and paxillin may increase with BPC-157, while the total amounts of these proteins may remain unchanged. This potentially suggests that BPC 157 may activate the FAK-paxillin pathway, which may be involved in the promotion of tendon fibroblast migration and cell adhesion.[6]
BPC-157 AND ANTIOXIDANT POTENTIAL
Studies in rat models have noted that BPC-157 appears to have antioxidant properties and may help to neutralize oxidative stress molecules like nitric oxide and malondialdehyde (MDA) and reactive oxygen species in the GI tract.[7] Research further hypothesized that modified Lactococcus lactis bacteria may increase the amount of the peptide in cell culture and can possibly deliver it to the GI tract.
Another study apparently aimed to evaluate early functional recovery and inflammation in tendon cells after the application of BPC-157[8]. The researchers utilized the Achilles functional index (AFI), myeloperoxidase activity, histological inflammatory cell influx, and vascular index as potential markers. The results suggest that BPC-157 may have improved functional recovery, as indicated by a potential increase in AFI values at all time points. This improvement was hypothesized to be attributed to its purported anti-inflammatory properties, including a potential decrease in myeloperoxidase (MPO) activity and histological inflammatory cell influx. Furthermore, BPC-157 potentially increased the formation of new blood vessels, as inferred by a possible increase in the vascular index. On the other hand, methylprednisolone also possibly decreased MPO activity and histological inflammatory cell influx, suggesting its potential anti-inflammatory action. However, methylprednisolone hypothetically decreased the formation of new blood vessels and may not have significantly affected early functional recovery.[8]
Another study examined the proposed action of a pentadecapeptide BPC-157 on inflammation and bone resorption in experimental periodontitis. Inflammation was assessed using the Evans blue plasma extravasation technique and histology. Evans blue extravasation hypothetically refers to the potential leakage of Evans blue dye from blood vessels into the surrounding tissues, which potentially indicates increased vascular permeability possibly associated with inflammation. The histological analysis appeared to provide visual evidence of inflammation. The results that the induction of periodontitis potentially caused a significant increase in Evans blue extravasation, histological signs of inflammation, and alveolar bone destruction. However, the administration of BPC 157 appeared to significantly reduce plasma extravasation, histological alterations potentially associated with inflammation, and alveolar bone resorption.[9]
BPC-157 AND AND THE CENTRAL NERVOUS SYSTEM
The potential of BPC-157 has been investigated in a murine model of traumatic brain injury (TBI), suggesting some positive outcomes. The peptide appeared to lead to a significant attenuation of TBI-induced damage and improved early outcomes based on the observed experiments. During the 24-hour post-injury period, there seemed to be minimal mortality. The severity of traumatic lesions, such as subarachnoid and intraventricular hemorrhage, brain laceration, and hemorrhagic laceration, appeared to be less pronounced in the BPC-157 group. Furthermore, there seemed to be a considerable improvement in brain edema. Hypothetically, if introduced prior to TBI, BPC-157 may have exhibited an improved conscious/unconscious/death ratio. BPC-157 potentially demonstrated a counteractive action against unconsciousness and lower mortality. Moreover, the immediate presentation of BPC-157 before injury may have also reduced the damage in murine models subjected to a force impulse.[10]
BPC-157 AND BEES
Colony collapse disorder (CCD) is a syndrome that causes entire colonies of bees to decline rapidly and die entirely, possibly due to Nosema ceranae fungal infection in the GI tract of bees. Experimental use of BPC-157 along with bee food noted significant improvement of the bee GI tract and hive survival.In this research, the peptide was successful for oral use in natural field settings to reduce the effect of CCD on bees which is the natural pollinator of many crop plants.
Future Research
BPC-157 is being actively studied in a number of cell culture and animal models. The peptide not only has the potential to assist in wound healing and vascular growth but also to study the regulation of these processes, especially in angiogenesis which is extremely crucial in wound healing, cancer progression, and embryo development. BPC-157 studies have reported minimal adverse effects, medium oral, and excellent subcutaneous bioavailability in mice. The dosage in mice (per kg) does not scale up to humans.
Disclaimer: The products mentioned are not intended for human or animal consumption. Research chemicals are intended solely for laboratory experimentation and/or in-vitro testing. Bodily introduction of any sort is strictly prohibited by law. All purchases are limited to licensed researchers and/or qualified professionals. All information shared in this article is for educational purposes only.
Our Advantage:
1. Faster delivery: Sample order in stock and 3-7 days for bulk production.
2. We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS. Or you also can choose your own shipping forwarder.
3. After-Sale Service:
1)International Authorized Third-Party Test For The Products You Demand.
2)60 Days Warranty of quality of goods.
Packing & Shipping:
1.As your requirements.
2. Prompt shipment after receipt of your order confirmation.
3.Transit could be DHL UPS TNT EMS Fedex and so on.
4. For mass orders,it will be delivered by air or sea.
5.Depending on your locationplease allow 1-5 business days for your order to arrive.
6.For small order please expect 3-7 days by UPS DHL EMS
7.For mass order please allow 5-8 days by air 15-30 days by sea.
Whatever you're looking for, we've got it!"Ready to explore further?
Inquiry directly for more details
About us
WuhanZhengtai Technology Co., Ltd is mainly engaged in the export of fine chemicals, cosmetic raw materials, food additives, pharmaceutical intermediates and other products; Our company is committed to the development of international market, our products are mainly exported to many countries and regions, such as Europe, America, South-east Asia, the Middle East and Africa etc.
Meanwhile, we possess of complete Q. A. And Q. C. System, supply chemical products with good quality and custom-tailored products according to our clients′ requirement. We have professional sales team, focus on quality and service, and we have achieved excellent performance over the 15 years. With our constant efforts and good service, We sincerely hope to establish long-term cooperation and common development with our customers.
Our advantages
Quality: Purity above 99%, directly produced by the manufacturer, can accept quality testing, and can also customize any content of powder, liquid, oil, etc.
Transport: We can accept sea freight, air freight, and express delivery, with a guarantee time of 1-2 weeks and a customs clearance rate of over 99%.
Service: In addition to powder, we also have liquids, water-based agents, oils, tablets, and professional customized synthesis routes. We provide you with professional guidance on product use, product synthesis, and product customization.
Price: We do not engage in price wars. We are manufacturer and can provide high quality products with factory price.
RFQ
Q: How to start orders or make payments?
A:You can send our your Purchase order(if your company has), or just send a simple confirmation by email or by Trade Manager, and we will send you Proforma Invoice with our bank details for your confirmation, then you can make payment accordingly.
Q: How to confirm the Product Quality before placing orders?
A:You can get samples for some products to test. You can send us your product specifications and requests,we will manufacture the products according to your requests.
Q: What's your MOQ?
A:For the high value product, our MOQ starts from 1box.
Q: Is there a discount?
A: Yes, for larger quantity, we always support with better price.
Q:How do you treat quality complaint?
First of all, our quality control will reduce the quality problem to near zero. If there is a quality problem caused by us, we will send you free goods for replacement or refund your loss.
Q:How to contact us ?
You can choose your interested products and send inquiry to us.
You can dial our telephone directly.